Literature DB >> 30448112

Prolonged QRS duration as a predictor of right ventricular dysfunction after balloon pulmonary angioplasty.

Ryotaro Asano1, Takeshi Ogo2, Keiko Ohta-Ogo3, Shigefumi Fukui4, Akihiro Tsuji4, Jin Ueda4, Nao Konagai4, Tetsuya Fukuda5, Yoshiaki Morita5, Teruo Noguchi6, Kengo Kusano6, Toshihisa Anzai6, Hatsue Ishibashi-Ueda3, Satoshi Yasuda6.   

Abstract

BACKGROUND: Balloon pulmonary angioplasty (BPA) has shown beneficial effects for chronic thromboembolic pulmonary hypertension (CTEPH). However, previous studies have shown less cardiac output improvement and symptoms remaining after BPA, implying poor right ventricular (RV) function recovery. Therefore, we investigated the residual RV dysfunction after BPA to reveal risk factors, clinical effects, and possible underlying histopathological mechanisms. METHODS AND
RESULTS: We investigated 61 consecutive CTEPH patients who underwent cardiovascular magnetic resonance before and 3 and 12 months after BPA series. Residual dysfunction (RD) of RV was defined as RV end-diastolic volume index >100 ml/m2 or RV ejection fraction (EF) <45% at 12-month follow-up. Patients were divided into RD (44%) and normalized dysfunction (ND) (56%) groups. Compared with the ND group, the RD group had significantly worse World Health Organization (WHO) functional class at follow-up. No significant hemodynamic differences were observed between the groups. On multivariable logistic regression analysis, male sex (odds ratio [OR] 12.5, p = 0.004) and prolonged QRS duration (OR 1.08, p = 0.029) were independently associated with residual RV dysfunction. Additionally, RV histopathology in 11 CTEPH autopsy cases showed that QRS duration was correlated with RV fibrosis area.
CONCLUSIONS: Relatively high percentage (44%) of residual RV dysfunction with worse WHO functional class was observed in CTEPH patients even after BPA. Prolonged QRS duration may predict poor recovery in RV function after BPA.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Balloon pulmonary angioplasty; Chronic thromboembolic pulmonary hypertension; Electrocardiography; Right ventricular dysfunction; Sex difference

Mesh:

Year:  2018        PMID: 30448112     DOI: 10.1016/j.ijcard.2018.11.026

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Protein Kinase C-Mediated Hyperphosphorylation and Lateralization of Connexin 43 Are Involved in Autoimmune Myocarditis-Induced Prolongation of QRS Complex.

Authors:  Chunlian Zhong; Huan Zhao; Xinwen Xie; Zhi Qi; Yumei Li; Lee Jia; Jinwei Zhang; Yusheng Lu
Journal:  Front Physiol       Date:  2022-03-28       Impact factor: 4.566

Review 2.  Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Authors:  Amanda Lloji; Urvashi Hooda; Jayakumar Sreenivasan; Ramin Malekan; Wilbert S Aronow; Gregg M Lanier
Journal:  Am J Cardiovasc Dis       Date:  2021-06-15

3.  Prognostic value of right ventricular native T1 mapping in pulmonary arterial hypertension.

Authors:  Ryotaro Asano; Takeshi Ogo; Yoshiaki Morita; Akiyuki Kotoku; Tatsuo Aoki; Kyoko Hirakawa; Sayuri Nakayama; Jin Ueda; Akihiro Tsuji; Mark T Waddingham; Yasutoshi Ohta; Tetsuya Fukuda; Keiko Ohta-Ogo; Hatsue Ishibashi-Ueda; Teruo Noguchi; Satoshi Yasuda
Journal:  PLoS One       Date:  2021-11-29       Impact factor: 3.240

4.  Association of Electrocardiographic Signs of Right Ventricular Hypertrophy and Clot Localization in Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Sylwia Sławek-Szmyt; Aleksander Araszkiewicz; Stanisław Jankiewicz; Anna Smukowska-Gorynia; Marek Grygier; Magdalena Janus; Maciej Lesiak; Tatiana Mularek-Kubzdela
Journal:  J Clin Med       Date:  2022-01-26       Impact factor: 4.241

5.  Right Ventricle Remodeling in Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Jixiang Liu; Peiran Yang; Han Tian; Kaiyuan Zhen; Colm McCabe; Lan Zhao; Zhenguo Zhai
Journal:  J Transl Int Med       Date:  2022-07-02

6.  Assessment of electrocardiographic markers of acute and long-term hemodynamic improvement in patients with pulmonary hypertension.

Authors:  Michał Piłka; Szymon Darocha; Marta Banaszkiewicz; Maria Wieteska-Miłek; Małgorzata Mańczak; Rafał Mańczak; Piotr Kędzierski; Michał Florczyk; Anna Dobosiewicz; Adam Torbicki; Marcin Kurzyna
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-04-26       Impact factor: 1.468

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.